Apidra
Apidra is a rapid-acting insulin that can be delivered via vial and syringe, pen, or insulin pump. Apidra is indicated for use in type 1 patients 4 years and older and adults with type 2 diabetes.
Features
Specs
Insulin Type:
Rapid-acting
Rapid-acting
Generic Name:
Insulin glulisine
Insulin glulisine
Delivery:
Syringe, pen, or pump
Syringe, pen, or pump
Form:
Analog
Analog
Concentrations:
U-100
U-100
Onset:
10 to 20 min.
10 to 20 min.
Peak:
30 to 90 min.
30 to 90 min.
Duration:
2 to 4 hours
2 to 4 hours